Point of Care Diagnostics

Global Cardiac Marker Analyzer Market Report 2020 Top Countries Data, Product Analysis, Companies Business And Marketing Strategy, Major Deals, Impact of Covid-19 | 360 Market Updates | Globe Newswire | 7/19/2020

Get a Sample PDF of Report @ https://www.360marketupdates.com/enquiry/request-sample/15914504 Key Highlights of the Report • In October 2017, Abbott completed its acquisition of Alere, concluding a deal first announced in February 2016. • Abbott Point of Care Diagnostics sales is driven by continued adoption of Abbott’s i-STAT handheld system. • Quidel’s cardiac immunoassay revenue was valued around USD 266.5 Million in 2019. • Cobas H232 POC system permits rapid …

Point-of-care Diagnostics Market is Anticipated to Surge with an Impressive CAGR of 6.9% During 2016 – 2024 | 7/17/2020

Healthcare Research Analysis Healthcare Point-of-care Diagnostics Market is Anticipated to Surge with an Impressive CAGR of 6.9% During 2016 – 2024 The global point of care diagnostics market is growing at a healthy CAGR. It is expected to receive a boost during the forecast period, taking the market evaluation US$11.7 bn by 2024 end. The market witnesses increasing advancements and investments in products, driven by a robust competition …

Follow Point of Care Diagnostics:    

COVID-19 Impact on Global Infectious Disease Point of Care Diagnostics Market Size, Status and Forecast 2020-2026 | 7/13/2020

Infectious Disease Point of Care Diagnostics Market This report focuses on the global Infectious Disease Point of Care Diagnostics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Disease Point of Care Diagnostics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America. The key players covered in this study Abbott Siemens GE Healthcare Accriva Terumo BioMerieux …

towards a cheap on-site test | 7/6/2020

… at Fig 1 in the pdf paper:-) Handyfuge-LAMP: low-cost and electricity-free centrifugation for isothermal SARS-CoV-2 detection in saliva. Author List Ethan Li , Adam Larson , Anesta Kothari, Manu Prakash✝ Abstract Point of care diagnostics for COVID-19 detection are vital to assess infection quickly and at the source so appropriate measures can be taken. The loop-mediated isothermal amplification (LAMP) assay has proven to be a …

How COVID-19 is transforming hospital design | 7/4/2020

… and the patient. It does not require a doctor. Doctors can see the patient remotely on video, conduct examination remotely through the Internet of Things, all tests are done inside within 15 minutes using Point of Care diagnostics, and medicines are dispensed automatically from a machine. (The award movie and the innovation can be seen at https://youtu.be/fGHuhqte500 The Health Innovation can be visited at https://event.healthinnovation.exchange/booth?id …

Google Alert - nova | 6/30/2020

… 30, 2020 NEWS Dicyclopentadiene Market Analysis, Size, Trends and Segmented Data by Sales Channels … Cole of Duty DowDuPont, Ningbo Jinhai Chenguang Chemical Corporation, NOVA Chemicals Corporation, Shandong Qilong Chemical, Sojitz Corporation, … Flag as irrelevant Point of Care Diagnostics Market Emerging Trends in COVID-19 Outbreak 2020 to 2027 By: Abbott … 3rd Watch News … Outbreak 2020 to 2027 By: Abbott Laboratories, Siemens AG, Roche , Sinocare , Johnson & Johnson, Sysmex Corporation, Nova Biomedical …

Point of Care Diagnostics (POCD) Market 2020 Leading Players: Roche, Abbott, BioMérieux, Abaxis, Siemens Healthineers, QIAGEN, Danaher, Instrumentation Laboratory, and Others | 6/22/2020

Contact Us Search for Home / Health / Point of Care Diagnostics (POCD) Market 2020 Leading Players: Roche, Abbott, BioMérieux, Abaxis, Siemens Healthineers, QIAGEN, Danaher, Instrumentation Laboratory, and Others Health News Science Technology Trending Point of Care Diagnostics (POCD) Market 2020 Leading Players: Roche, Abbott, BioMérieux, Abaxis, Siemens Healthineers, QIAGEN, Danaher, Instrumentation Laboratory, and Others Convenient Healthcare & Innovation Accelerating POCD Market: Industry Insights & Trends 30 mins ago Point of care diagnostics helps …

Global Molecular Diagnostics Market (2020 to 2024) – Insights & Forecast with Potential Impact of COVID-19 – ResearchAndMarkets.com | Financial Buzz | 6/20/2020

… cost, dearth of trained professionals, urgent need for proper infrastructure and delay in the approval of new molecular diagnostic tests. A few notable trends include progressing sample-to-answer molecular diagnostics market, growth in point of care diagnostics (poct), booming medical devices industry, innovation and technical developments, emergence of liquid biopsy solutions, targeting anti-biotic resistance, decentralization of diagnostic testing, advances in genomics and proteomics. The global molecular diagnostics market …

Point-of-care Diagnostics Market is Anticipated to Progress at CAGR of 6.9% from 2016 to 2024 | 6/19/2020

Healthcare Research Analysis Healthcare Point-of-care Diagnostics Market is Anticipated to Progress at CAGR of 6.9% from 2016 to 2024 The global point of care diagnostics market is growing at a healthy CAGR. It is expected to receive a boost during the forecast period, taking the market evaluation US$11.7 bn by 2024 end. The market witnesses increasing advancements and investments in products, driven by a robust competition. The …

Global Molecular Diagnostics Market (2020 to 2024) - Insights & Forecast with Potential Impact of COVID-19 - ResearchAndMarkets.com | Business Wire | 6/19/2020

… cost, dearth of trained professionals, urgent need for proper infrastructure and delay in the approval of new molecular diagnostic tests. A few notable trends include progressing sample-to-answer molecular diagnostics market, growth in point of care diagnostics (poct), booming medical devices industry, innovation and technical developments, emergence of liquid biopsy solutions, targeting anti-biotic resistance, decentralization of diagnostic testing, advances in genomics and proteomics. The global molecular diagnostics market …

As Per New Report, Global Point of Care Diagnostics Market Set to Expand Massively with CAGR of 11.8% to Reach US$ 70.89 Bn by 2027 | 6/17/2020

Selbyville, Delaware, Global Point of Care Diagnostics Market report added by Market Study Report that gives meticulous investigation of current scenario of the market size, share, demand, growth, trends, companies active in the industry and forecasts for the coming years. Competitive Landscape and Point of Care Diagnostics Market Share Analysis: The market for point of care diagnostics is expected to grow, owing to factors such as increasing incidences of infectious …

Global Molecular Diagnostics Market (by Application, Technology, End-Use & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024) | The Wapakoneta Daily News | 6/15/2020

… cost, dearth of trained professionals, urgent need for proper infrastructure and delay in the approval of new molecular diagnostic tests. A few notable trends include progressing sample-to-answer molecular diagnostics market, growth in point of care diagnostics (poct), booming medical devices industry, innovation and technical developments, emergence of liquid biopsy solutions, targeting anti-biotic resistance , decentralization of diagnostic testing, advances in genomics and proteomics. The global molecular diagnostics market …

Point of Care Diagnostics Market Anticipated to Achieve Lucrative Growth by 2027 | CAGR: 3.2% | 6/5/2020

The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding at a CAGR of 3.2%, according to a new report by Grand View Research, Inc. Continuous advancement in the development of highly sensitive and specific miniaturized biosensors, based on microfluidic systems along with handheld devices, is anticipated to drive the market. These systems are capable of automation, integration, and multiplex detection, suitable …

Invivoscribe Launches COVID-19 Diagnostic Testing With Option To Participate In SARS-CoV-2 Antibody And Vaccine Program | PR Newswire | 4/28/2020

… and track the immune response in subjects infected with the SARS-CoV-2 virus. Using these large international datasets we can rapidly identify specific antibody paratopes generated in response to the virus to optimize point of care diagnostics and identify the best epitopes for vaccine production.” About Invivoscribe, Inc. and LabPMM, LLC. Invivoscribe is a privately-held biotechnology company dedicated to Improving Lives with Precision Diagnostics ® . Invivoscribe and its wholly …

Global $24.1 Bn Point of Care (POC) Diagnostics Market Outlook, 2020-2027 - ResearchAndMarkets.com | Benzinga | 4/15/2020

The “Point of Care Diagnostics Market Size, Share & Trends Analysis Report by Product (Glucose Testing, Blood Gas/ Electrolytes, Cancer Marker), by End Use (Clinics, Hospital), by Region, and Segment Forecasts, 2020 - 2027” report has been added to ResearchAndMarkets.com’s offering. The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding at a CAGR of 3.2%. Continuous advancement in the development of highly sensitive …

Global $24.1 Bn Point of Care (POC) Diagnostics Market Outlook, 2020-2027 – ResearchAndMarkets.com | Financial Buzz | 4/15/2020

The “Point of Care Diagnostics Market Size, Share & Trends Analysis Report by Product (Glucose Testing, Blood Gas/ Electrolytes, Cancer Marker), by End Use (Clinics, Hospital), by Region, and Segment Forecasts, 2020 – 2027” report has been added to ResearchAndMarkets.com’s offering. The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding at a CAGR of 3.2%. Continuous advancement in the development of highly sensitive …

Portable X-ray Devices Market, Size, Share, Outlook and Growth Opportunities 2019-2026 | 4/13/2020

… ray is a form of electromagnetic ionizing radiation that is used to monitor the abnormalities in the body, especially bones. The invention of portable X-ray devices has contributed majorly in the field of point of care diagnostics . These devices are very useful when the treatment has to be completed in a short duration of time. X-ray devices can be folded in a small package for transportation, and medical …

Point of Care (POC) Diagnostics Industry Forecast to 2027 - Introduction of CLIA Waived Tests, Rise in Funding from Government & Private Institutions | Benzinga | 4/8/2020

… Share & Trends Analysis Report by Product (Glucose Testing, Blood Gas/ Electrolytes, Cancer Marker), by End Use (Clinics, Hospital), by Region, and Segment Forecasts, 2020 - 2027” report has been added to ResearchAndMarkets.com’s offering. The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding at a CAGR of 3.2%. Continuous advancement in the development of highly sensitive and specific miniaturized biosensors, based on microfluidic …

Point of Care (POC) Diagnostics Industry Forecast to 2027 – Introduction of CLIA Waived Tests, Rise in Funding from Government & Private Institutions | Financial Buzz | 4/8/2020

… Share & Trends Analysis Report by Product (Glucose Testing, Blood Gas/ Electrolytes, Cancer Marker), by End Use (Clinics, Hospital), by Region, and Segment Forecasts, 2020 – 2027” report has been added to ResearchAndMarkets.com’s offering. The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding at a CAGR of 3.2%. Continuous advancement in the development of highly sensitive and specific miniaturized biosensors, based on microfluidic …

Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Product, By End Use, By Region And Segment Forecasts, 2020 - 2027 | PR Newswire | 4/7/2020

Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Product, By End Use, By Region And Segment Forecasts, 2020 - 2027 News provided by Apr 06, 2020, 17:30 ET Share this article NEW YORK , April 6, 2020 /PRNewswire/ – Point of Care Diagnostics Market Size, Share & Trends Analysis Report By Product (Glucose Testing, Blood Gas/ Electrolytes, Cancer Marker), By End Use (Clinics, Hospital), By Region, And Segment Forecasts, 2020 - 2027 …

MSU Researcher Seeks Faster Coronavirus Test | 4/7/2020

… you hope will lead to faster ways of testing people for Coronavirus. What can you tell me about that? DR. BRETT ETCHEBARNE: My research as an emergency medicine physician has been directed toward rapid point of care diagnostics of infection for the better part of probably eight years now. We’ve previously focused on specific pathogens affecting your lungs, pneumonia or urinary tract infections, wounds, etc. When COVID arose, it was …

DST funds Pune healthcare startup for rapid detection of COVID-19 | 4/6/2020

Comments  Listen to this Article The Department of Science & Technology (DST) has funded ‘Module Innovations”, a Pune-based healthcare startup working on point of care diagnostics to develop its platform technology for rapid diagnosis of diseases to develop a test kit for detecting COVID-19 within 10 to 15 minutes. Using the proven concept from its flagship product ‘USense’, Module is now developing nCoVSENSEs (TM) which is a rapid …

FDA Clears Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer Used for Critically Ill Patients in Acute Care Settings | Business Wire | 3/31/2020

… blood gas testing solution that delivers fast, accurate results and increases workflow efficiencies. A safe operating environment amid growing concerns about cybersecurity threats in healthcare is also important,” said Christoph Pedain, PhD, Head of Point of Care Diagnostics , Siemens Healthineers. “The RAPIDPoint 500e Blood Gas Analyzer has become a trusted instrument in Europe’s endeavor to combat COVID-19 and to help address an unprecedented demand for blood gas testing in …

Point of Care/POC Diagnostics Market worth $46.7 billion by 2024 | 3/31/2020

Point of Care/POC Diagnostics Market worth $46.7 billion by 2024 Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024 ( EMAILWIRE.COM , March 31, 2020 ) The global point-of-care diagnostics market is projected to reach USD 46.7 billion by 2024 from USD 28.5 billion in 2019, at a CAGR …

Coronavirus (COVID-19) Update: FDA Issues first Emergency Use Authorization for Point of Care Diagnostic | PR Newswire | 3/21/2020

… of-care diagnostics, we are moving into a new phase of testing, where tests will be much more easily accessible to Americans who need them,” said HHS Secretary Alex Azar . “With the development of point of care diagnostics , Americans who need tests will be able to get results faster than ever before. More and more options for reliable, convenient testing are becoming available at an incredibly rapid pace, thanks to …

COVID-19

The Global Medical Ventilators Market to Generate Revenues of Over $2 Billion During the Period 2020 −2025 - Market Research by Arizton | PR Newswire | 4/28/2020

… Outlook and Forecast 2020-2025 is expected to grow at a CAGR of approximately 11% during the period 2019−2025. This market research report includes data-driven and deep market insights on the impact of COVID-19 across geographies, segments, and vendor landscape. Leverage Arizton’s market analysis to take real-time strategic business decisions and enhance your product portfolios. Key Highlights Offered in the Report: The US is the major contributor to …

Food and Drug Administration

ThermoGenesis Receives Acknowledgement Letter from FDA Allowing Its SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit for Distribution | PR Newswire | 4/16/2020

… THMO ), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that on Wednesday April 15 th , following submission of notification to the U.S. Food and Drug Administration (FDA), the Company has received the necessary acknowledgement letter which provided confirmation that the ThermoGenesis’ SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit has been appropriately validated in accordance with …

CDC

OPKO Health’s BioReference Laboratories Partners with Hospitals Nationwide to Provide Prioritized Testing to Inpatients with Suspected Coronavirus Disease 2019 (COVID-19) | PR Newswire | 4/6/2020

… continue to strive to keep our current turnaround time for non-hospital patients at 2-3 days from the time we receive the specimen,” said Dr. Cohen. Providers should refer to the most current CDC guidelines for further information on appropriate testing of patients, available here https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-criteria.html . About COVID-19 Testing at BioReference Laboratories, Inc. BioReference Laboratories is accepting specimens for COVID-19 testing …

Home Health

Global Point-Of-Care Diagnostics Market is Projected to Grow at a CAGR of 10.4% from 2019 to 2024 | Globe Newswire | 1/2/2020

Dublin, Jan. 02, 2020 (GLOBE NEWSWIRE) – The “Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast … countries, increasing incidence of target conditions, and increasing inclination toward home healthcare across the globe are driving the market for point-of-care diagnostics. However, product recalls, a lack of alignment with test results obtained …

Patient Monitoring

IDTechEx Launches Healthcare Sensor Innovations Conference in North America | PR Newswire | 12/4/2019

… focus on the latest developments in the use of wearables and sensors in continuous monitoring of the human body and point of care diagnostics. The conference will be held in San Jose , USA on the … of chronic disease. “ Attendees looking to learn more about continuous patient monitoring and point-of-care diagnostics are encouraged to join IDTechEx masterclasses held on 16 th and 19 th of March 2020 . Our expert …

Biosensors

IDTechEx Launches Healthcare Sensor Innovations Conference in North America | PR Newswire | 12/4/2019

… focus on the latest developments in the use of wearables and sensors in continuous monitoring of the human body and point of care diagnostics. The conference will be held in San Jose , USA on the … understanding and market outlooks across key topic areas of wearables, biosensors, electronic skin patches, and flexible, printed and stretchable sensors. To find out more and to register for Healthcare Sensor Innovations USA 2020, please visit …

Diagnostic Tests

Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Report 2019-2023 with Coverage of Roche, Abbott Laboratories, BioMrieux, Siemens Healthineers | PR Newswire | 12/3/2019

Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Report 2019-2023 with Coverage of Roche, Abbott Laboratories, BioMrieux, Siemens Healthineers News provided by Research and Markets Dec 03, 2019, 11:00 ET DUBLIN , Dec. 3, 2019 /PRNewswire/ – The “Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market: Size, Trends and Forecasts (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. The report provides a regional analysis of the …

Home Care

Point of Care (POC) Diagnostics Market - Global Outlook and Forecast Report 2019-2024: Sepsis Biomarkers, Stroke Markers, Thyroid Testing, DNA Testing, Endocrine Testing | PR Newswire | 12/2/2019

Point of Care (POC) Diagnostics Market - Global Outlook and Forecast Report 2019-2024: Sepsis Biomarkers, Stroke Markers, Thyroid Testing, DNA Testing, Endocrine Testing News provided by Dec 02, 2019, 08:00 ET Share this article DUBLIN The “Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast to 2024” report has been added to …

Molecular Diagnostics

Point of Care (POC) Diagnostics Market - Global Outlook and Forecast Report 2019-2024: Sepsis Biomarkers, Stroke Markers, Thyroid Testing, DNA Testing, Endocrine Testing | PR Newswire | 12/2/2019

… Markers, Thyroid Testing, DNA Testing, Endocrine Testing News provided by Dec 02, 2019, 08:00 ET Share this article DUBLIN The “Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation … diagnostics market is segmented into lateral flow assays, dipsticks, microfluidics, molecular diagnostics, and immunoassays. The microfluidics segment is expected to register the highest growth rate during the forecast period. Technological advancements and increasing initiatives by …

Home Healthcare

Point of Care (POC) Diagnostics Market - Global Outlook and Forecast Report 2019-2024: Sepsis Biomarkers, Stroke Markers, Thyroid Testing, DNA Testing, Endocrine Testing | PR Newswire | 12/2/2019

… Markers, Thyroid Testing, DNA Testing, Endocrine Testing News provided by Dec 02, 2019, 08:00 ET Share this article DUBLIN The “Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation … countries, increasing incidence of target conditions, and increasing inclination toward home healthcare across the globe are driving the market for point-of-care diagnostics. However, product recalls, a lack of alignment with test results obtained …

National Cancer Institute

Global Immunoassay Market Outlook and Forecast to 2025 - Leading Vendors are Roche Diagnostics, bioMerieux, Abbott Laboratories, Becton Dickinson & Company, and Siemens Healthineers | PR Newswire | 11/28/2019

… to grow at a high CAGR during the forecast period. Immunoassays offer a broad array of applications in disease diagnosis with high specificity and sensitivity when compared to other tests. According to the National Cancer Institute, in the US, an estimated 1,735,530 new cancer cases were diagnosed and approximately 609,640 deaths were recorded in 2018. The biggest infectious disease killers, currently in the US, are pneumonia and flu, which are …

Biotech

Point Of Care Diagnostics Market Worth $46.7 Billion by 2024 - Exclusive Report by MarketsandMarkets™ | PR Newswire | 11/21/2019

PRNewswire/ – According to the new market research report “ Point Of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global … US), Sekisui Diagnostics (US), Nova Biomedical (US), EKF Diagnostics (UK), AccuBioTech ( China ), and Trinity Biotech ( Ireland ). Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting Browse Related Reports: Point of Care Molecular Diagnostics Market by …

Remote Monitoring

Point Of Care Diagnostics Market Worth $46.7 Billion by 2024 - Exclusive Report by MarketsandMarkets™ | PR Newswire | 11/21/2019

PRNewswire/ – According to the new market research report “ Point Of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global … can be attributed to the increasing preference for home and remote monitoring and rising demand for rapid tests among home care users. Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=106829185 North …

Rapid Diagnostics

Abbott Reports Third-Quarter 2019 Results | PR Newswire | 10/16/2019

… 76 111 (6.6) (8.3) (7.8) (6.6) (6.3) (6.4) Point of Care 112 32 144 7.0 4.1 6.3 7.0 5.6 6.7 Rapid Diagnostics 283 194 477 3.6 (6.4) (0.7) 3.6 (2.8) 0.8 % Change vs. 9M18 Sales … negatively impacted by lower non-governmental organization purchases in Africa . Point of Care Diagnostics sales increased 6.3 percent on a reported basis in the third quarter, including an unfavorable 0.4 percent effect of foreign exchange …

Digital Health

Brown Gibbons Lang & Company Joins the DxPx Conference at MEDICA as an Alliance Partner | PR Newswire | 10/14/2019

… With the support of numerous key sponsors, DxPx’s founders successfully build the world’s first and only partnering conference focused on licensing, financing, co-development and M&A opportunities for Dx, Digital Dx, and Digital Health & Research Tools. For more information, and to register for DxPx, please visit www.dxpx-conference.com . SOURCE Brown Gibbons Lang & Company Related Links https://www.bglco.com …

Genomic Analysis

DermTech Announces Appointment of Kevin Sun as Chief Financial Officer – Company Announcement - FT.com | Financial Times | 9/16/2019

… Prior to DexCom , Mr. Sun held various roles of increasing responsibility at Biosite Incorporated , a NASDAQ-listed leader in rapid point of care diagnostics. Mr. Sun holds a B.S. in Business with a dual major … leading to improved patient care and lower costs. DermTech provides genomic analysis of skin samples collected non-invasively using an adhesive patch rather than a scalpel. DermTech markets and develops products that facilitate the early …

Wearable Technology

IDTechEx Research Discusses Design Considerations for Electronic Textiles | PR Newswire | 7/8/2019

… technologies. For more information on IDTechEx Research and Consultancy contact [email protected] or visit www.IDTechEx.com . To find out more about Wearable Technology research available from IDTechEx visit www.IDTechEx.com/WT or to connect with others on … IDTechEx Research on Wearable Technology Healthcare Sensor Innovations 2019: Enabling point of care diagnostics and continuous monitoring SOURCE IDTechEx Related Links https://www.idtechex.com …

Alere

Global Cardiac Marker Analyzer Market Report 2020 Top Countries Data, Product Analysis, Companies Business And Marketing Strategy, Major Deals, Impact of Covid-19 | 360 Market Updates | Globe Newswire | 7/19/2020

Get a Sample PDF of Report @ https://www.360marketupdates.com/enquiry/request-sample/15914504 Key Highlights of the Report • In October 2017, Abbott completed its acquisition of Alere, concluding a deal first announced in February 2016. • Abbott Point of Care Diagnostics sales is driven by continued adoption of Abbott’s i-STAT handheld system. • Quidel’s cardiac immunoassay revenue was valued around USD 266.5 Million in 2019. • Cobas H232 POC system permits rapid …

Global Point of Care (POC) Diagnostics Market Trends 2017-2019, and CAGR Projections to 2023 | Benzinga | 10/10/2019

Dublin, Oct. 10, 2019 (GLOBE NEWSWIRE) – The “Point of Care Diagnostics: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. Globally, the diagnostic testing business is a multi-billion-dollar industry with intense … global POC testing market is led by Roche, Johnson & Johnson, Alere, Abbott, Siemens and Danaher. Report Scope This study will describe the market for POC diagnostics at the global level. It focuses on the accelerating …

Abbott Laboratories

Global Molecular Diagnostics Market (2020 to 2024) - Insights & Forecast with Potential Impact of COVID-19 - ResearchAndMarkets.com | Business Wire | 6/19/2020

… approval of new molecular diagnostic tests. A few notable trends include progressing sample-to-answer molecular diagnostics market, growth in point of care diagnostics (poct), booming medical devices industry, innovation and technical developments, emergence of … with the company profiles of leading players (Roche Holding AG, Abbott Laboratories, Danaher Corporation, Hologic Inc., Biomerieux SA and Thermo Fisher Scientific Inc.) are also presented in detail. Key Topics Covered: 1. Overview 1.1 Diagnostics …

Abbott (ABT) Beats on Q1 Earnings, Suspends ‘20 Guidance - April 16, 2020 - Zacks.com | 4/16/2020

Abbott Laboratories ( ABT - Free Report ) reported first-quarter 2020 adjusted earnings from continuing operations of 65 cents per share, exceeding the Zacks Consensus Estimate by 18.2%. Meanwhile, the adjusted figure improved 3.2% from the prior … outbreak. However, Molecular Diagnostics jumped 30.3%, on an organic basis. Point of Care Diagnostics sales too improved 2.7%, on an organic basis. Rapid Diagnostics sales improved 5.4%, on an organic basis, in the March-end …

Siemens

FDA Clears Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer Used for Critically Ill Patients in Acute Care Settings | Business Wire | 3/31/2020

TARRYTOWN, N.Y.–(BUSINESS WIRE)–Mar 31, 2020– Siemens Healthineers announced today that its latest critical care testing solution, the RAPIDPoint® 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration. The … healthcare is also important,” said Christoph Pedain, PhD, Head of Point of Care Diagnostics, Siemens Healthineers. “The RAPIDPoint 500e Blood Gas Analyzer has become a trusted instrument in Europe’s endeavor to combat COVID-19 and …

Point Of Care Diagnostics Market Worth $46.7 Billion by 2024 - Exclusive Report by MarketsandMarkets™ | PR Newswire | 11/21/2019

PRNewswire/ – According to the new market research report “ Point Of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global … Prominent players in this market are Abbott (US), Roche ( Switzerland ), Siemens ( Germany ), Danaher (US), Becton, Dickinson, and Company (US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio Diagnostic Systems (US), Sekisui …

Siemens Healthineers

FDA Clears Siemens Healthineers RAPIDPoint 500e Blood Gas Analyzer Used for Critically Ill Patients in Acute Care Settings | Business Wire | 3/31/2020

TARRYTOWN, N.Y.–(BUSINESS WIRE)–Mar 31, 2020– Siemens Healthineers announced today that its latest critical care testing solution, the RAPIDPoint® 500e Blood Gas Analyzer, has received clearance from the U.S. Food and Drug Administration. The … healthcare is also important,” said Christoph Pedain, PhD, Head of Point of Care Diagnostics, Siemens Healthineers. “The RAPIDPoint 500e Blood Gas Analyzer has become a trusted instrument in Europe’s endeavor to combat COVID-19 and …

Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Report 2019-2023 with Coverage of Roche, Abbott Laboratories, BioMrieux, Siemens Healthineers | PR Newswire | 12/3/2019

Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Report 2019-2023 with Coverage of Roche, Abbott Laboratories, BioMrieux, Siemens Healthineers News provided by Research and Markets Dec 03, 2019, 11:00 ET DUBLIN , Dec. 3, 2019 /PRNewswire/ – The “Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market: Size, Trends and Forecasts (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. The report provides a regional analysis of the …

Roche Diagnostics

Point of Care Diagnostics Market Size Worth $24.1 Billion by 2027 | CAGR: 3.2%: Grand View Research, Inc. | PR Newswire | 3/19/2020

SAN FRANCISCO The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding at a CAGR of 3.2%, according to a new report by Grand View Research, Inc … instance, in September 2019 , BioMed X completed its collaboration with Roche Diagnostics for the development of nanomaterial-based biosensors for point of care testing Read 250 page research report with ToC on “Point of Care …

Point of Care Diagnostics Market Size Worth $24.1 Billion by 2027 | CAGR: 3.2%: Grand View Research, Inc. | Markets Insider | Business Insider | 3/19/2020

SAN FRANCISCO , March 19, 2020 /PRNewswire/ – The global point of care diagnostics market size is expected to reach USD 24.1 billion by 2027, expanding at a CAGR of 3.2%, according to a new report by … instance, in September 2019 , BioMed X completed its collaboration with Roche Diagnostics for the development of nanomaterial-based biosensors for point of care testing Read 250 page research report with ToC on “Point of Care …

Quidel

Point Of Care Diagnostics Market Worth $46.7 Billion by 2024 - Exclusive Report by MarketsandMarkets™ | PR Newswire | 11/21/2019

PRNewswire/ – According to the new market research report “ Point Of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global … US), Johnson & Johnson (US), Instrumentation Laboratory (US), PTS Diagnostics (US), Quidel (US), Chembio Diagnostic Systems (US), Sekisui Diagnostics (US), Nova Biomedical (US), EKF Diagnostics (UK), AccuBioTech ( China ), and Trinity Biotech ( Ireland ). Browse Adjacent Markets: Medical …

Point of Care (POC) Diagnostics Market Review and Outlook 2017-2023 - Leading Players are Roche, Johnson & Johnson, Alere, Abbott, Siemens, and Danaher | PR Newswire | 10/10/2019

DUBLIN , Oct. 10, The “Point of Care Diagnostics: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. This study will describe the market for POC diagnostics at the global level. It focuses on … xPOCT Market Share Market Participants and Market Shares Beckman Coulter Quidel Alere Chapter 15 Urine Chemistry Testing Segment Overview Market Size xPOCT Market Share Market Participants and Market Shares Roche Siemens Chapter 16 Other POC …

Siemens Healthcare

Global Point of Care (POC) Diagnostics Market Trends 2017-2019, and CAGR Projections to 2023 | Benzinga | 10/10/2019

Dublin, Oct. 10, 2019 (GLOBE NEWSWIRE) – The “Point of Care Diagnostics: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. Globally, the diagnostic testing business is a multi-billion-dollar industry with intense … International Technidyne Corp. Nova Biomedical Radiometer America Inc. Roche Diagnostics Siemens Healthcare Chapter 7 Cardiac Marker Testing Segment Overview Market Size xPOCT Market Share Market Participants and Market Shares Abbott Alere Roche Response Biomedical Siemens …

Point of Care (POC) Diagnostics Market Review and Outlook 2017-2023 - Leading Players are Roche, Johnson & Johnson, Alere, Abbott, Siemens, and Danaher | PR Newswire | 10/10/2019

DUBLIN , Oct. 10, The “Point of Care Diagnostics: Technologies and Global Markets” report has been added to ResearchAndMarkets.com’s offering. This study will describe the market for POC diagnostics at the global level. It focuses on … International Technidyne Corp. Nova Biomedical Radiometer America Inc. Roche Diagnostics Siemens Healthcare Chapter 7 Cardiac Marker Testing Segment Overview Market Size xPOCT Market Share Market Participants and Market Shares Abbott Alere Roche Response Biomedical Siemens …

Dexcom

DermTech Announces Appointment of Kevin Sun as Chief Financial Officer | Business Wire | 9/16/2019

… the medical device and diagnostic industries. From 2008 to 2018, Mr. Sun served in various executive and management roles for DexCom, Inc., a NASDAQ-listed medical device company, including most recently as Vice President, Corporate … responsibility at Biosite Incorporated, a NASDAQ-listed leader in rapid point of care diagnostics. Mr. Sun holds a B.S. in Business with a dual major in Accounting and Finance, a minor in Psychology, a Masters …

DermTech Announces Appointment of Kevin Sun as Chief Financial Officer | Business Wire | 9/16/2019

… the medical device and diagnostic industries. From 2008 to 2018, Mr. Sun served in various executive and management roles for DexCom, Inc., a NASDAQ-listed medical device company, including most recently as Vice President, Corporate … responsibility at Biosite Incorporated, a NASDAQ-listed leader in rapid point of care diagnostics. Mr. Sun holds a B.S. in Business with a dual major in Accounting and Finance, a minor in Psychology, a Masters …

Laura Wood

Global Point-Of-Care Diagnostics Market is Projected to Grow at a CAGR of 10.4% from 2019 to 2024 | Globe Newswire | 1/2/2020

Dublin, Jan. 02, 2020 (GLOBE NEWSWIRE) – The “Point of Care Diagnostics Market by Product (Glucose, Infectious Disease (Hepatitis C, Influenza, Respiratory), Coagulation), Platform (Microfluidics, Immunoassays), Mode (Prescription & OTC), End-User (Hospitals, Home Care) - Global Forecast … Research services providing focused, comprehensive and tailored research. CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call …

Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Report 2019-2023 with Coverage of Roche, Abbott Laboratories, BioMrieux, Siemens Healthineers | PR Newswire | 12/3/2019

Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market Report 2019-2023 with Coverage of Roche, Abbott Laboratories, BioMrieux, Siemens Healthineers News provided by Research and Markets Dec 03, 2019, 11:00 ET DUBLIN , Dec. 3, 2019 /PRNewswire/ – The “Global Infectious Disease In Vitro Diagnostic (IVD) and Molecular Test Market: Size, Trends and Forecasts (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. The report provides a regional analysis of the …

Miles D. White

Abbott Reports Third-Quarter 2019 Results | PR Newswire | 10/16/2019

… latest technology for screening and protecting the U.S. blood and plasma supply. “We’re performing exceptionally well across several areas,” said Miles D. White , chairman and chief executive officer, Abbott. “We’re right on track to achieve … negatively impacted by lower non-governmental organization purchases in Africa . Point of Care Diagnostics sales increased 6.3 percent on a reported basis in the third quarter, including an unfavorable 0.4 percent effect of foreign exchange …

Abbott Reports First-Quarter 2019 Results | PR Newswire | 4/17/2019

… meet the growing demand for infectious disease testing. “We’re right on track with our expectations to start the year,” said Miles D. White , chairman and chief executive officer, Abbott. “All of our key long-term … help laboratories meet the growing demand for infectious disease testing. Point of Care Diagnostics sales decreased 4.8 percent on a reported basis in the first quarter, including an unfavorable 0.6 percent effect of foreign exchange …

John Dobak

DermTech Announces Appointment of Kevin Sun as Chief Financial Officer – Company Announcement - FT.com | Financial Times | 9/16/2019

… Prior to DexCom , Mr. Sun held various roles of increasing responsibility at Biosite Incorporated , a NASDAQ-listed leader in rapid point of care diagnostics. Mr. Sun holds a B.S. in Business with a dual major … its clear benefit for physicians and patients,” said Mr. Kemper. John Dobak , M.D., the CEO of DermTech , commented, “I am extremely excited to have Kevin join our team. His experiences helping to drive the tremendous …

DermTech Announces Appointment of Kevin Sun as Chief Financial Officer | Business Wire | 9/16/2019

… Prior to DexCom, Mr. Sun held various roles of increasing responsibility at Biosite Incorporated, a NASDAQ-listed leader in rapid point of care diagnostics. Mr. Sun holds a B.S. in Business with a dual major … its clear benefit for physicians and patients,” said Mr. Kemper. John Dobak, M.D., the CEO of DermTech, commented, “I am extremely excited to have Kevin join our team. His experiences helping to drive the tremendous …